Valuation Beacon Pharmaceuticals PLC

Stocks

End-of-day quote Dhaka S.E. 28/09/2026			5-day change	1st Jan Change
100.60 ^BDT	-0.98%		-1.95%	-3.82%

09-03	Beacon Pharmaceuticals PLC Announces Appointment of Anindya Sarkar as Company Secretary, Effective September 1, 2026	CI
07-02	Beacon Pharmaceuticals Limited Announces Appointment of Md. Emroj Hossain as Company Secretary, Effective July 1, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Market Cap ¹	14,022	28,552	59,667	56,595	35,528	24,463
Change	-	103.62%	108.98%	-5.15%	-37.22%	-31.14%
Enterprise Value (EV) ¹	15,590	30,705	62,950	63,573	45,525	34,426
Change	-	96.96%	105.01%	0.99%	-28.39%	-24.38%
P/E	36.8x	33.1x	63.8x	111x	68.2x	25.8x
PBR	3.03x	5.33x	10x	9.52x	5.83x	3.67x
PEG	-	0x	7.66x	-2.4x	31.14x	0.3x
Capitalization / Revenue	2.51x	4.01x	7.44x	6.65x	3.32x	1.95x
EV / Revenue	2.79x	4.31x	7.85x	7.47x	4.25x	2.74x
EV / EBITDA	18.5x	17.6x	30.6x	42.8x	19.3x	11.6x
EV / EBIT	46.8x	22.5x	38.9x	65.7x	24.9x	14.7x
EV / FCF	-67.9x	-54.6x	-54.9x	-18.2x	-14.7x	-3,997x
FCF Yield	-1.47%	-1.83%	-1.82%	-5.5%	-6.81%	-0.03%
Dividend per Share ²	-	1.5	1.6	1.6	2	2.1
Rate of return	-	1.21%	0.62%	0.65%	1.3%	1.98%
EPS ²	1.648	3.737	4.048	2.207	2.255	4.097
Distribution rate	-	40.1%	39.5%	72.5%	88.7%	51.3%
Net sales ¹	5,591	7,121	8,023	8,510	10,702	12,543
EBITDA ¹	844.5	1,747	2,057	1,487	2,356	2,966
EBIT ¹	333.5	1,362	1,617	967.7	1,828	2,334
Net income ¹	380.7	863.2	935	509.8	521	946.5
Net Debt ¹	1,568	2,153	3,282	6,978	9,997	9,963
Reference price ²	60.70	123.60	258.30	245.00	153.80	105.90
Nbr of stocks (in thousands)	231,000	231,000	231,000	231,000	231,000	231,000
Announcement Date	20/12/21	20/12/21	22/11/22	05/12/23	10/12/24	03/04/26

¹BDT in Million²BDT

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEACON PHARMACEUTICALS PLC	-	-	-	-	191M
ELI LILLY AND COMPANY	33.65x	12.19x	24.78x	0.59%	1,055B
JOHNSON & JOHNSON	30.17x	6.71x	18.78x	1.98%	654B
ABBVIE INC.	33.43x	7.82x	16.17x	2.59%	467B
ROCHE HOLDING AG	19.59x	4.78x	11.84x	2.78%	348B
NOVARTIS AG	20.4x	5.31x	13.17x	3.01%	275B
ASTRAZENECA PLC	21.19x	4.39x	12.5x	2.01%	258B
AMGEN INC.	26.19x	6.82x	12.15x	2.43%	224B
GILEAD SCIENCES, INC.	-45.65x	6.64x	25.94x	2.18%	187B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	171B
Average	16.70x	6.53x	15.99x	2.45%	363.85B
Weighted average by Cap.	24.18x	7.87x	18.13x	1.96%